Clinical Observation on Treating Chronic Obstructive Pulmonary Disease Due to Phlegm-Heat Stagnation in Lung with Yuebi Banxia Decoction
Objective To study the clinical effect of Yuebi Banxia Decoction in treating chronic obstructive pulmonary disease(COPD)due to phlegm-heat stagnation in lung.Methods A total of 973 patients with COPD due to phlegm-heat stagnation in lung treated in the Fifth People's Hospital of Zhuhai were selected and assigned into a control group(n=487)and an observation group(n=486)according to the random number table method.The control group was treated with salmeterol/fluticasone,and the observation group was additionally treated with Yuebi Banxia Decoction.The clinical effect,TCM syndrome score,arterial oxygen saturation(SaO2),and pulmonary function indicators were observed and measured before and after treatment.Results After treatment,the levels of forced expiratory volume in the 1st second(FEV1),FEV1/forced vital capacity(FVC)%,and SaO2 elevated in each group(P<0.05),and the observation group had higher total response rate,FEV1,FEV1/FVC%,and SaO2 than the control group(P<0.01).After treatment,the TCM syndrome score and arterial carbon dioxide pressure(PaCO2)level declined in each group(P<0.01),and the observation group had lower TCM syndrome score and PaCO2 than the control group(P<0.01).Conclusion Yuebi Banxia Decoction can alleviate the clinical symptoms,improve pulmonary functions,and ameliorate arterial blood gas disorders in the patients with phlegm-heat stagnation in lung,being worthy of popularization in clinical practice.
Yuebi Banxia Decoctionsyndrome of phlegm-heat stagnation in lungchronic obstructive pulmonary disease(COPD)pulmonary functionarterial blood gas
NETL
NSTL
万方数据
